Umbilical cord blood-derived mesenchymal stem cells: New therapeutic weapons for idiopathic dilated cardiomyopathy?

International Journal of Cardiology

Volumn 177, Issue 3, 2014, Pages 809-818

  Roura, Santiago ^a   Gálvez Montón, Carolina ^a   Bayes Genis, Antoni ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cell therapy; Idiopathic dilated cardiomyopathy; Mesenchymal stem cells; Therapeutic agents; Umbilical cord blood; Vascular potential

Indexed keywords

CD34 ANTIGEN; EARLY GROWTH RESPONSE FACTOR 3; GRANULOCYTE COLONY STIMULATING FACTOR;

ANGIOGENESIS; BONE MARROW CELL; CARDIAC REGENERATION; CARDIOVASCULAR PARAMETERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONGESTIVE CARDIOMYOPATHY; DISEASE ASSOCIATION; DISEASE MODEL; ENDOTHELIAL DYSFUNCTION; FEASIBILITY STUDY; HEART BLOOD VESSEL; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE CELL; HISTOPATHOLOGY; HUMAN; MEDICAL RESEARCH; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MYOCARDIAL INTEGRITY; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATIENT SAFETY; QUALITY OF LIFE; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION; TRANSLATIONAL RESEARCH; UMBILICAL CORD BLOODDERIVED MESENCHYMAL STEM CELL; ANIMAL; CARDIOMYOPATHY, DILATED; CLINICAL TRIAL (TOPIC); CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; FETUS BLOOD; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PROCEDURES; TRANSPLANTATION;

ANIMALS; CARDIOMYOPATHY, DILATED; CLINICAL TRIALS AS TOPIC; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HUMANS; MESENCHYMAL STROMAL CELLS;

EID: 84920134707     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.09.128     Document Type: Review

References (93)

1. B.J. Maron, J.A. Towbin, G. Thiene, C. Antzelevitch, D. Corrado, and D. Arnett Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 113 2006 1807 1816
2. J.A. Towbin, and A. Lorts Arrhythmias and dilated cardiomyopathy common pathogenetic pathways? J Am Coll Cardiol 57 2011 2169 2171
3. J.A. Towbin, A.M. Lowe, S.D. Colan, L.A. Sleeper, E.J. Orav, and S. Clunie Incidence, causes, and outcomes of dilated cardiomyopathy in children JAMA 296 2006 1867 1876
4. J.L. Jefferies, and J.A. Towbin Dilated cardiomyopathy Lancet 375 2010 752 762
5. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, and P.A. Poole-Wilson ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
6. J.A. Towbin, and N.E. Bowles The failing heart Nature 415 2002 227 233
7. S. Roura, and A. Bayes-Genis Vascular dysfunction in idiopathic dilated cardiomyopathy Nat Rev Cardiol 6 2009 590 598
8. L.A. Sánchez, C.E. Guerrero-Beltrán, A.M. Cordero-Reyes, G. García-Rivas, and G. Torre-Amione Use of stem cells in heart failure treatment: where we stand and where we are going Methodist Debakey Cardiovasc J 9 2013 195 200
9. J.M. Gho, G.J. Kummeling, S. Koudstaal, Jansen Of Lorkeers SJ, P.A. Doevendans, and F.W. Asselbergs Cell therapy, a novel remedy for dilated cardiomyopathy? A systematic review J Card Fail 19 2013 494 502
10. J. Haas, K.S. Frese, Y.J. Park, A. Keller, B. Vogel, and A.M. Lindroth Alterations in cardiac DNA methylation in human dilated cardiomyopathy EMBO Mol Med 5 2013 413 429
11. S. Roura, C. Gálvez-Montón, J.M. Pujal, L. Casani, M.A. Fernández, and L. Astier New insights into lipid raft function regulating myocardial vascularization competency in human idiopathic dilated cardiomyopathy Atherosclerosis 230 2013 354 364
12. S. Roura, R. Cal, C. Gálvez-Montón, E. Revuelta-Lopez, L. Nasarre, and L. Badimon Inverse relationship between raft LRP1 localization and non-raft ERK1,2/MMP9 activation in idiopathic dilated cardiomyopathy: Potential impact in ventricular remodeling Int J Cardiol 176 2014 Oct 20 805 814
13. R. Gu, J. Bai, L. Ling, L. Ding, N. Zhang, and J. Ye Increased expression of integrin-linked kinase improves cardiac function and decreases mortality in dilated cardiomyopathy model of rats PLoS ONE 7 2012 e31279
14. M.M. Marijianowski, P. Teeling, J. Mann, and A. Becker Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assessment J Am Coll Cardiol 25 1995 1263 1272
15. Z. Gunja-Smith, A.R. Morales, R. Romanelli, and J.F. Woessner Jr. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links Am J Pathol 148 1996 1639 1648
16. M. Pauschinger, D. Knopf, S. Petschauer, A. Doerner, W. Poller, and P.L. Schwimmbeck Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio Circulation 99 1999 2750 2756
17. T. Mela, T.E. Meyer, L.A. Pape, E.S. Chung, G.P. Aurigemma, and B.H. Weiner Coronary arterial dimension-to-left ventricular mass ratio in idiopathic dilated cardiomyopathy Am J Cardiol 83 1999 1277 1280
18. S. Roura, F. Planas, C. Prat-Vidal, R. Leta, C. Soler-Botija, and F. Carreras Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation Eur J Heart Fail 9 2007 995 1002
19. D. Abraham, R. Hofbauer, R. Schäfer, R. Blumer, P. Paulus, and A. Miksovsky Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy Circ Res 87 2000 644 647
20. R. Schäfer, D. Abraham, P. Paulus, R. Blumer, M. Grimm, and J. Wojta Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy Circulation 108 2003 1585 1591
21. C. Huang, X. Zhang, J.M. Ramil, S. Rikka, L. Kim, and Y. Lee Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice Circulation 121 2010 675 683
22. J. Liu, and X. Li Novel porcine models of myocardial ischemia/infarction - technical progress, modified electrocardiograms validating, and future application R.M. Millis, Advances in electrocardiograms - clinical applications 2012 InTech 175 190
23. C. Gálvez-Montón, C. Prat-Vidal, S. Roura, J. Farré, C. Soler-Botija, and A. Llucià-Valldeperas Transposition of a pericardial-derived vascular adipose flap for myocardial salvage after infarct Cardiovasc Res 91 2011 659 667
24. C. Gálvez-Montón, C. Prat-Vidal, S. Roura, C. Soler-Botija, A. Llucià-Valldeperas, and I. Díaz-Güemes Post-infarction scar coverage using a pericardial-derived vascular adipose flap. Pre-clinical results Int J Cardiol 166 2013 469 474
25. N. Dib, E.B. Diethrich, A. Campbell, A. Gahremanpour, M. McGarry, and S.R. Opie A percutaneous swine model of myocardial infarction J Pharmacol Toxicol Methods 53 2006 256 263
26. E. Lukács, B. Magyari, L. Tóth, Ö. Petneházy, Z. Petrási, and T. Simor Evaluation of experimental myocardial infarction models via electromechanical mapping and magnetic resonance imaging Can J Physiol Pharmacol 91 2013 617 624
27. F.A. Recchia, and V. Lionetti Animal models of dilated cardiomyopathy for translational research Vet Res Commun 31 2007 35 41
28. F.S. Carvalho, A. Burgeiro, R. Garcia, A.J. Moreno, R.A. Carvalho, and P.J. Oliveira Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy Med Res Rev 34 2014 106 135
29. S.R. Houser, K.B. Margulies, A.M. Murphy, F.G. Spinale, G.S. Francis, and S.D. Prabhu Animal models of heart failure: a scientific statement from the American Heart Association Circ Res 111 2012 131 150
30. M.S. Allworth, D.B. Church, J.E. Maddison, R. Einstein, P. Brennan, and N. Abdul Hussein Effect of enalapril in dogs with pacing-induced heart failure Am J Vet Res 56 1995 85 94
31. F.Z. Ahmed, R.S. Khattar, A.M. Zaidi, L. Neyses, D. Oceandy, and M. Mamas Pacing-induced cardiomyopathy: pathophysiological insights through matrix metalloproteinases Heart Fail Rev 16 2013 Jul
32. L.A. Nikolaidis, D. Elahi, T. Hentosz, A. Doverspike, R. Huerbin, and L. Zourelias Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy Circulation 110 2004 955 961
33. H.M. Blau, T.R. Brazelton, and J.M. Weimann The evolving concept of a stem cell: entity or function? Cell 105 2001 829 841
34. S. Roura, C. Gálvez-Montón, and A. Bayes-Genis The challenges for cardiac vascular precursor cell therapy: lessons from a very elusive precursor J Vasc Res 50 2013 304 323
35. C. Soler-Botija, J.R. Bagó, and A. Bayes-Genis A bird's-eye view of cell therapy and tissue engineering for cardiac regeneration Ann N Y Acad Sci 1254 2012 57 65
36. C. Gálvez-Montón, C. Prat-Vidal, S. Roura, C. Soler-Botija, and A. Bayes-Genis Cardiac tissue engineering and the bioartificial heart Rev Esp Cardiol 66 2013 391 399
37. M. Chen, Z.C. Fan, X.J. Liu, J.L. Deng, L. Zhang, and L. Rao Effects of autologous stem cell transplantation on ventricular electrophysiology in doxorubicin-induced heart failure Cell Biol Int 30 2006 576 582
38. S. Fuchs, R. Baffour, Y.F. Zhou, M. Shou, A. Pierre, and F.O. Tio Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia J Am Coll Cardiol 37 2001 1726 1732
39. N. Nagaya, K. Kangawa, T. Itoh, T. Iwase, S. Murakami, and Y. Miyahara Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy Circulation 112 2005 1128 1135
40. C.K. Sun, L.T. Chang, J.J. Sheu, C.H. Chiang, F.Y. Lee, and C.J. Wu Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy Crit Care Med 37 2009 1197 1205
41. B. Vrtovec, G. Poglajen, M. Sever, L. Lezaic, D. Domanovic, and P. Cernelc Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy J Card Fail 17 2011 272 281
42. + stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up Circ Res 112 2013 165 173
43. E.A. Bocchi, F. Bacal, G. Guimarães, A. Mendroni, A. Mocelin, and A.E. Filho Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failure Int J Cardiol 138 2010 94 97
44. S. Seth, B. Bhargava, R. Narang, R. Ray, S. Mohanty, and G. Gulati The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial a long-term follow-up study J Am Coll Cardiol 55 2010 1643 1644
45. U. Fischer-Rasokat, B. Assmus, F.H. Seeger, J. Honold, D. Leistner, and S. Fichtlscherer A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy Circ Heart Fail 2 2009 417 423
46. H.F. Martino, P.S. Oliveira, F.C. Souza, P.C. Costa, E. Assunção E Silva, and R. Villela A safety and feasibility study of cell therapy in dilated cardiomyopathy Braz J Med Biol Res 43 2010 989 995
47. F. Benetti, E. Peñherrera, T. Maldonado, Y.D. Vera, V. Subramanian, and L. Geffner Direct myocardial implantation of human fetal stem cells in heart failure patients: long-term results Heart Surg Forum 13 2010 E31 E35
48. R.A. Kalil, D. Ott, R. Sant'Anna, E. Dias, J.P. Marques-Pereira, and A. Delgado-Cañedo Autologous transplantation of bone marrow mononuclear stem cells by mini-thoracotomy in dilated cardiomyopathy: technique and early results Sao Paulo Med J 126 2008 75 81
49. + cell transplantation in patients with nonischemic dilated cardiomyopathy Circulation 128 2013 S42 S49
50. S. Arnous, A. Mozid, and A. Mathur The Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy (REGENERATE-DCM) trial: study design Regen Med 6 2011 525 533
51. G.P. Fadini, I. Baesso, M. Albiero, S. Sartore, C. Agostini, and A. Avogaro Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau Atherosclerosis 197 2008 496 503
52. F. Timmermans, J. Plum, M.C. Yöder, D.A. Ingram, B. Vandekerckhove, and J. Case Endothelial progenitor cells: identity defined? J Cell Mol Med 13 2009 87 102
53. J.D. Pearson Endothelial progenitor cells - an evolving story Microvasc Res 79 2010 162 168
54. M.R. Richardson, and M.C. Yoder Endothelial progenitor cells: quo vadis? J Mol Cell Cardiol 50 2011 266 272
55. J.S. Pober Just the FACS or stalking the elusive circulating endothelial progenitor cell Arterioscler Thromb Vasc Biol 32 2012 837 838
56. A.H. Kumar, and N.M. Caplice Clinical potential of adult vascular progenitor cells Arterioscler Thromb Vasc Biol 30 2010 1080 1087
57. J. Oswald, S. Boxberger, B. Jørgensen, S. Feldmann, G. Ehninger, and M. Bornhäuser Mesenchymal stem cells can be differentiated into endothelial cells in vitro Stem Cells 22 2004 377 384
58. J. Schmeckpeper, Y. Ikeda, A.H. Kumar, P. Metharom, S.J. Russell, and N.M. Caplice Lentiviral tracking of vascular differentiation in bone marrow progenitor cells Differentiation 78 2009 169 176
59. A. Bayes-Genis, C. Soler-Botija, J. Farré, P. Sepúlveda, A. Raya, and S. Roura Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents J Mol Cell Cardiol 49 2010 771 780
60. J.R. Bagó, C. Soler-Botija, L. Casaní, E. Aguilar, M. Alieva, and N. Rubio Bioluminescence imaging of cardiomyogenic and vascular differentiation of cardiac and subcutaneous adipose tissue-derived progenitor cells in fibrin patches in a myocardium infarct model Int J Cardiol 169 2013 288 295
61. Q. Xiong, K.L. Hill, Q. Li, P. Suntharalingam, A. Mansoor, and X. Wang A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling Stem Cells 29 2011 367 375
62. V. Sanchez-Freire, A.S. Lee, S. Hu, O.J. Abilez, P. Liang, and F. Lan Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells J Am Coll Cardiol 64 2014 436 448
63. N. Ma, C. Stamm, A. Kaminski, W. Li, H.D. Kleine, and B. Müller-Hilke Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice Cardiovasc Res 66 2005 45 54
64. S. Roura, J.M. Pujal, and A. Bayes-Genis Umbilical cord blood for cardiovascular cell therapy: from promise to fact Ann N Y Acad Sci 1254 2012 66 70
65. S.M. Watt, F. Gullo, M. van der Garde, D. Markeson, R. Camicia, and C.P. Khoo The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential Br Med Bull 108 2013 25 53
66. A.J. Friedenstein, K.V. Petrakova, A.I. Kurolesova, and G.P. Frolova Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues Transplantation 6 1968 230 247
67. A.J. Friedenstein, R.K. Chailakhjan, and K.S. Lalykina The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells Cell Tissue Kinet 3 1970 393 403
68. M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, and J.D. Mosca Multilineage potential of adult human mesenchymal stem cells Science 284 1999 143 147
69. M. Lee, S.Y. Jeong, J. Ha, M. Kim, H.J. Jin, and S.J. Kwon Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo Biochem Biophys Res Commun 446 2014 983 989
70. T. Zhao, Z.N. Zhang, Z. Rong, and Y. Xu Immunogenicity of induced pluripotent stem cells Nature 474 2011 212 215
71. E. Gluckman Milestones in umbilical cord blood transplantation Blood Rev 25 2011 255 259
72. H. Mayani, and P.M. Lansdorp Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells Stem Cells 16 1998 153 165
73. J.N. Barker, D.J. Weisdorf, T.E. DeFor, B.R. Blazar, P.B. McGlave, and J.S. Miller Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy Blood 105 2005 1343 1347
74. C. Prat-Vidal, S. Roura, J. Farré, C. Gálvez, A. Llach, and C.E. Molina Umbilical cord blood-derived stem cells spontaneously express cardiomyogenic traits Transplant Proc 39 2007 2434 2437
75. S. Roura, J.R. Bagó, C. Soler-Botija, J.M. Pujal, C. Gálvez-Montón, and C. Prat-Vidal Human umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivo PLoS ONE 7 2012 e49447
76. S. Roura, J. Farré, L. Hove-Madsen, C. Prat-Vidal, C. Soler-Botija, and C. Gálvez-Montón Exposure to cardiomyogenic stimuli fails to transdifferentiate human umbilical cord blood-derived mesenchymal stem cells Basic Res Cardiol 105 2010 419 430
77. S. Roura, J.R. Bagó, C. Gálvez-Montón, J. Blanco, and A. Bayes-Genis In vitro characterization of the molecular machinery regulating umbilical cord blood mesenchymal stem cell angiogenesis: a step towards multipotent stem cell therapy for vascular regeneration J Stem Cell Res Ther 3 2013 140
78. S. Roura, C. Gálvez-Montón, and A. Bayes-Genis Bioluminescence imaging: a shining future for cardiac regeneration J Cell Mol Med 17 2013 693 703
79. W.H. Zimmermann, and T. Eschenhagen Cardiac tissue engineering for replacement therapy Heart Fail Rev 8 2003 259 269
80. B.J. Kang, H. Kim, S.K. Lee, J. Kim, Y. Shen, and S. Jung Umbilical-cord-blood-derived mesenchymal stem cells seeded onto fibronectin-immobilized polycaprolactone nanofiber improve cardiac function Acta Biomater 10 2014 3007 3017
81. S.W. Kim, H. Han, G.T. Chae, S.H. Lee, S. Bo, and J.H. Yoon Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model Stem Cells 24 2006 1620 1626
82. D.L. Brutsaert, A.L. Meulemans, K.R. Sipido, and S.U. Sys Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle Circ Res 62 1988 358 366
83. D. Ungureanu-Longrois, J.L. Balligand, I. Okada, W.W. Simmons, L. Kobzik, and C.J. Lowenstein Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture Circ Res 77 1995 486 493
84. X.L. Qi, T.L. Nguyen, L. Andries, S.U. Sys, and J.L. Rouleau Vascular endothelial dysfunction contributes to myocardial depression in ischemia-reperfusion in the rat Can J Physiol Pharmacol 76 1998 35 45
85. J.P. Bell, S.I. Mosfer, D. Lang, F. Donaldson, and M.J. Lewis Vitamin C and quinapril abrogate LVH and endothelial dysfunction in aortic-banded guinea pigs Am J Physiol Heart Circ Physiol 281 2001 H1704 H1710
86. X.L. Qi, D.J. Stewart, H. Gosselin, A. Azad, P. Picard, and L. Andries Improvement of endocardial and vascular endothelial function on myocardial performance by captopril treatment in postinfarct rat hearts Circulation 100 1999 1338 1345
87. R.E. Feldmann Jr., K. Bieback, M.H. Maurer, A. Kalenka, H.F. Bürgers, and B. Gross Stem cell proteomes: a profile of human mesenchymal stem cells derived from umbilical cord blood Electrophoresis 26 2005 2749 2758
88. H.J. Lee, J.K. Lee, H. Lee, J.W. Shin, J.E. Carter, and T. Sakamoto The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease Neurosci Lett 481 2010 30 35
89. A.M. Marmont New horizons in the treatment of autoimmune diseases: immunoablation and stem cell transplantation Annu Rev Med 51 2000 115 134
90. K.F. Adams Systems biology and heart failure: concepts, methods, and potential research applications Heart Fail Rev 15 2010 371 398
91. H. Drexler, and B. Hornig Endothelial dysfunction in human disease J Mol Cell Cardiol 31 1999 51 60
92. J.J. Gajarsa, and R.A. Kloner Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities Heart Fail Rev 16 2011 13 21
93. T.E. Ichim, F. Solano, R. Brenes, E. Glenn, J. Chang, and K. Chan Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy Reprod Biomed Online 16 2008 898 905